Cargando…
Identification of a novel immune signature for optimizing prognosis and treatment prediction in colorectal cancer
Background: Globally, colorectal cancer (CRC) is one of the most lethal malignant diseases. However, the currently approved therapeutic options for CRC failed to acquire satisfactory treatment efficacy. Tailoring therapeutic strategies for CRC individuals can provide new insights into personalized p...
Autores principales: | Li, Yan, Li, Yiyi, Xia, Zijin, Zhang, Dun, Chen, Xiaomei, Wang, Xinyu, Liao, Jing, Yi, Wei, Chen, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714135/ https://www.ncbi.nlm.nih.gov/pubmed/34898475 http://dx.doi.org/10.18632/aging.203771 |
Ejemplares similares
-
Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer
por: Li, Yayun, et al.
Publicado: (2022) -
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020) -
Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer
por: Li, Jianxin, et al.
Publicado: (2022) -
Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
por: Dai, Siqi, et al.
Publicado: (2020) -
Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)